Eye-Tracking study seeks to uncover hidden cognitive gains in rett syndrome drug

This study tests whether eye-tracking tasks can detect changes in attention and learning in people with Rett syndrome who are starting a new medication called trofinetide. Researchers will compare eye movements and heart rate before and after 4 weeks of treatment in 20 participants. The goal is to find better ways to measure thinking abilities that are not affected by movement or speech problems.